Stocks analysis

Analysis for CBOE

  • 📈 Growth — 22/30
  • 💰 Profitability — 17/20
  • 🏦 Financial Health — 18/20
  • 💵 Valuation — 12/20
  • ⚠️ Risk — 7/10
Overall Score: 72/100

Summary:


📈 Growth & Financial Trajectory

Across eight quarters from 2023 Q4 to 2026 Q1, Revenues rose from about $968.7M to $1.2728B (+31%), while Net Income advanced from about $212M to $385.7M (+82%), signaling improving profitability despite volatility. Gross margin expanded from roughly 51.5% to about 57.3%, with cash flow strength evident as 2026 Q1 Operating Cash Flow (continuing) reached about $1.96B.

💰 Margins & Cash Flow

Gross Margin trended to the mid-50s and climbed to ~57% in 2026 Q1. Operating cash flow remained positive across quarters and peaked at $1.96B in 2026 Q1, underscoring robust cash generation. Investing cash flow was generally negative or mixed, reflecting ongoing capex, while financing activity fluctuated.

🛡️ Balance Sheet & Liquidity

Total assets grew to roughly $11.07B in 2026 Q1; Equity about $5.37B; Long-term debt near $1.44B. Current assets ~$6.22B vs current liabilities ~$4.49B, yielding a rough current ratio of 1.38. Leverage remains modest and liquidity appears resilient.

⚠️ Key Drivers & Risks

  • Drivers: Market data/trading volumes and derivatives activity; volatility-linked revenue potential.
  • Risks: Cyclicality of financial markets; sensitivity to volumes and regulatory shifts.

Similar Companies